as on January 29, 2026 at 4:02 pm IST
Day's Low
Day's High
1.76%
Downside
4.67%
Upside
52 Week's Low
52 Week's High
10.72%
Downside
73.05%
Upside
as on January 29, 2026 at 4:02 pm IST
Market Cap
₹400.02 Cr
Return on Equity (ROE)
4.93
PE Ratio (TTM)
54.98
Return on capital employed (ROCE)
8.21
Industry PE ratio
39.98
Beta (LTM)
0.82
P/B Ratio
1.61
Dividend Yield
0PEG Ratio
-28.19
Quarterly Earnings Growth YOY
-117.65
EPS (TTM)
2.5
Sector
Pharmaceuticals
Book Value
51.49
Technical Analysis
Bullish
View Technical Analysis
as on January 29, 2026 at 4:02 pm IST
Zim Laboratories in the last 5 years
Lowest (6.12x)
June 11, 2018
Industry (39.98x)
January 28, 2026
Today (54.98x)
January 28, 2026
Highest (198.80x)
July 1, 2021
Today’s Price to Earnings Ratio: 54.98x
Compare market cap, revenue, PE, and other key metrics of Zim Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 400.02 | -2.19% | 0.66 | 12 | 379 | |
| NA | 25.91 | -17.82% | 0.00 | 2 | 22 | |
| NA | 215.28 | 320.95% | 0.61 | 8 | 70 | |
| NA | 3.07 | -12.76% | 0.65 | NA | 18 | |
| NA | 516.39 | 39.94% | 0.61 | 23 | 108 |
Get share price movements and forecasts by analysts on Zim Laboratories.
Source: S&P Global Market Intelligence
Search interest for Zim Laboratories Ltd Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Zim Laboratories.
Zim Laboratories Ltd’s net profit fell -117.65% since last year same period to ₹0.42Cr in the Q2 2025-2026. On a quarterly growth basis, Zim Laboratories Ltd has generated 77.54% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 per share on 22 May 2019 - translating a dividend yield of 2.01%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 73.23 Cr → 90.75 Cr (in ₹), with an average increase of 19.3% per quarter
Price Rise
![]()
In the last 7 days, ZIMLAB stock has moved up by 5.5%
Retail Holding Up
![]()
Retail Investor have increased holdings from 66.51% to 66.52% in Dec 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -1.87 Cr → -0.42 Cr (in ₹), with an average increase of 345.2% per quarter
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.00% to 0.02% in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 33.26% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 17.8% return, outperforming this stock by 45.7%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.8% return, outperforming this stock by 164.1%
| Organisation | Zim Laboratories Ltd |
| Industry | Pharmaceuticals |
| CEO | Anwar S Daud |
| E-voting on shares | Click here to vote |
Zim Laboratories share price today stands at ₹73.39 as on at the close of the market. Zim Laboratories share today touched a day high of ₹76.82 and a low of ₹72.1.
Zim Laboratories touched a 52 week high of ₹127 and a 52 week low of ₹65.52. Zim Laboratories share price today i.e. is closed at ₹73.39, which is -42.21% down from its 52 week high and 12.01% up from its 52 week low.
Zim Laboratories market capitalisation is ₹400.02 Cr as on .
To buy Zim Laboratories shares, you need to follow these steps:
Zim Laboratories trading volume is 37.20K as on . This means that 37.20K shares of Zim Laboratories were bought and sold on the stock market during today's trading session.